NCT00289770View on ClinicalTrials.gov

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

November 1, 2004

Primary Completion Date

December 20, 2004

Study Completion Date

December 20, 2004

Conditions

Hepatitis BHepatitis A

Interventions

BIOLOGICAL

Twinrix™

Intramuscular injection, 3 doses

Trial Locations (1)

2610

GSK Investigational Site, Wilrijk

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY